Skip to main content

Table 3 Association between B symptoms and clinical variables.

From: Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients – analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO

Variable

Category

n

B symptoms present

p

Sex

Female

311

169 (54.3)

0.577

 

Male

353

184 (52.1)

 

Age

< 75 years

496

261 (52.6)

0.631

 

GE 75 years

168

92 (54.8)

 

Stage

Stage 0–2

246

94 (38.2)

< 0.001

 

Stage 3–4

418

259 (62.0)

 

Performance status

Level 0–1

470

210 (44.7)

< 0.001

 

Level 2–4

183

137 (74.9)

 

LDH

Normal

216

95 (44.0)

< 0.001

 

Elevated

381

223 (58.5)

 

Bone marrow aspirate

Negative

508

266 (52.4)

0.040

 

Positive

57

38 (66.7)

 

Bone marrow trephine

Negative

487

246 (50.5)

< 0.001

 

Positive

89

62 (69.7)